Related Experiment Videos
Acute glomerulonephritis.
1Apollo Indraprastha Hospital, New Delhi.
Indian Journal of Pediatrics
|May 8, 2000
Summary
Acute glomerulonephritis (AGN), often post-streptococcal, presents with hematuria and edema. While typically resolving well, severe cases require expert management and evaluation, potentially including biopsy and immunosuppression.
Area of Science:
- Nephrology
- Immunology
- Infectious Diseases
Background:
- Acute glomerulonephritis (AGN) is characterized by sudden onset hematuria, edema, hypertension, and renal dysfunction.
- Post-streptococcal AGN (PSAGN), common in developing nations, involves immune complex deposition following beta-hemolytic streptococcal infections.
- Differential diagnoses include other infections, primary glomerular diseases, connective tissue disorders, vasculitis, and hereditary nephritis.
Purpose of the Study:
- To summarize the clinical presentation, etiology, and management of acute glomerulonephritis, with a focus on post-streptococcal AGN.
- To highlight the diagnostic considerations and prognostic factors in AGN.
- To outline the indications for renal biopsy and aggressive treatment in severe or atypical cases.
Main Methods:
- Review of clinical features and common etiologies of AGN.
- Discussion of diagnostic criteria and differential diagnoses.
- Outline of management strategies based on disease severity and specific findings.
Main Results:
- PSAGN is the most frequent cause of AGN in developing countries, typically presenting with classic symptoms but sometimes only hematuria.
- Most patients with PSAGN experience rapid resolution and have an excellent prognosis.
- Severe cases, non-streptococcal AGN, or unresolving GN necessitate thorough evaluation, including renal biopsy, and potentially immunosuppressive therapy for conditions like crescentic GN.
Conclusions:
- Post-streptococcal AGN is a common, usually self-limiting condition, but prompt evaluation and management are crucial for severe or atypical presentations.
- Renal biopsy is indicated for severe azotemia, systemic features, non-streptococcal causes, or lack of resolution to guide treatment, including immunosuppression for crescentic GN.